BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2187 related articles for article (PubMed ID: 19595059)

  • 1. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of the daily blood glucose profiles of impaired glucose tolerance and type 2 diabetes mellitus subjects by continuous glucose monitoring system].
    Wang XL; Lu JM; Pan CY; Mu YM; Dou JT; Ba JM
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):674-7. PubMed ID: 16681924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between the amplitude of glucose excursion and plasma 8-iso prostaglandin F2alpha level in subjects with different types of glucose regulation].
    Zheng FP; Wang Z; Li H; Jia CF; Zhang N; Yuan HD
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):651-4. PubMed ID: 19595055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus.
    Wang C; Lv L; Yang Y; Chen D; Liu G; Chen L; Song Y; He L; Li X; Tian H; Jia W; Ran X
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):810-5. PubMed ID: 21854404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycemic excursions in people with normal glucose tolerance in Chengdu].
    He LP; Wang C; Zhong L; Yang YZ; Long Y; Zhang XX; Shu SQ; Yu HL; Yu TT; Wang WP; Wang Y; Ran XW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):704-7. PubMed ID: 19764578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
    Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The distributive characteristics of impaired glucose metabolism subcategories in Chinese adult population].
    Yang ZJ; Yang WY; Li GW;
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2128-31. PubMed ID: 14720420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired glucose tolerance is not associated with lipid intolerance.
    Henkel E; Temelkova-Kurktschiev T; Koehler C; Pietzsch J; Leonhardt W; Hanefeld M
    Diabetes Nutr Metab; 2002 Apr; 15(2):84-90. PubMed ID: 12059096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of glycometabolism in the first-degree relatives of type 2 diabetes patients assessed by continuous glucose monitoring system].
    Chen LL; Li Q; Wang W; Cui C; Yu P; Bao LL; Wang J; Zhou J; Bao YQ; Jia WP; Sun YQ; Zhang JC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):655-8. PubMed ID: 19595056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
    Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.
    Moreau F; Weiller MA; Rosner V; Weiss L; Hasselmann M; Pinget M; Kessler R; Kessler L
    Horm Metab Res; 2008 Jul; 40(7):502-6. PubMed ID: 18415892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
    Guerrero-Romero F; Rodríguez-Morán M
    Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].
    Tao MF; Zhu JP; Zhou J; Lu W; Qin W; Teng YC; Jia WP
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):659-63. PubMed ID: 19595057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimating intraday blood glucose variability through self-monitoring of blood glucose in people with impaired glucose tolerance and type 2 diabetes].
    Lü LF; Wang C; Liu GJ; Chen DW; Chen LH; Li YH; Zhou J; Jia WP; Ran XW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):95-100. PubMed ID: 21355311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The glycemic excursions in normal glucose tolerance individuals revealed by continuous glucose monitoring system].
    Yu M; Zhou J; Xiang KS; Lu HJ; Ma XJ; Lu W
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1788-90. PubMed ID: 15631775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 110.